Adam Brys is a Dermatology physician affiliated with Duke Medical Center. OpenAlex indexes 19 publications with 263 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
290 Baker Ave Ste N220
Concord, MA 017422190
Telephone
978-369-9023Provider last certified this registry record 1 Nov 2024.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202518 payments
- Janssen Biotech, Inc.Program year20253 payments
- Amgen Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
26.4%Azole Antifungal12.8%Ketoconazole100%Part D≥94 patientsTetracycline-class Drug4.9%Doxycycline Hyclate100%Part D≥32 patients+ 4 more classes in this area
Dermatology
20.5%Corticosteroid14%Triamcinolone Acetonide90%Triamcinolone acetonide10%Part D + Part B≥112 patientsOther antifungals for topical use3.5%Ciclopirox100%Part D≥21 patients+ 3 more classes in this area
Sensory organs
18.4%Corticosteroid18.4%Clobetasol Propionate49%Hydrocortisone29%Betamethasone Dipropionate22%Part D≥70 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cutaneous Vasculopathy and Recalcitrant Lower-Extremity Ulcerations
Annals of Internal Medicine Clinical Cases
2023 - 13955 Recalcitrant lower-extremity ulcerations: Importance of rebiopsy
Journal of the American Academy of Dermatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Abbruzzese, MD
Duke Medical Center
David Durack, MD
Duke Medical Center
Leonard Prosnitz, MD
Duke Medical Center
Scott Cousins, MD
Duke Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”